The Maldives Food and Drug Authority (MFDA) has announced an immediate ban on two syrups commonly used as painkillers for children after detecting the presence of harmful industrial chemicals.

In a statement issued today, the MFDA revealed that diethylene glycol and ethylene glycol, dangerous industrial substances, were discovered in two medications during routine quality screenings. The affected products are:

• Mefnac Suspension Syrup, manufactured by Pakistan's Efroze Chemical Pvt Ltd.


• Axcel Mefenamic Acid Suspension Syrup, produced by Malaysia's Kotra Pharma.

Both medications have been prohibited from import, sale, and use while the MFDA sends samples for further testing abroad. Pharmacies and warehouses have been instructed to isolate any stock of these products to prevent accidental use or contamination.

Diethylene glycol and ethylene glycol are toxic chemicals with a history of causing severe health crises. Tragic incidents linked to these substances include the deaths of 368 children in Indonesia and 70 children in Gambia, who ingested medications contaminated with these chemicals.

The MFDA emphasizes its commitment to ensuring the safety and quality of medications available in the Maldives. The public is advised to refrain from using these syrups and consult healthcare providers for alternative treatments.